Avid Bioservices, Inc. Stock price

Equities

CDMO

US05368M1062

Pharmaceuticals

Real-time Estimate Cboe BZX 11:37:41 2024-03-28 am EDT 5-day change 1st Jan Change
7.085 USD +1.50% Intraday chart for Avid Bioservices, Inc. +3.06% +8.92%
Sales 2024 * 139M Sales 2025 * 166M Capitalization 441M
Net income 2024 * -16M Net income 2025 * -4M EV / Sales 2024 * 3.18 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.67 x
P/E ratio 2024 *
-26.3 x
P/E ratio 2025 *
-112 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.95%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.80%
1 week-1.83%
Current month-9.11%
1 month-14.36%
3 months+3.41%
6 months-31.57%
Current year+7.38%
More quotes
1 week
6.51
Extreme 6.505
7.05
1 month
5.90
Extreme 5.9
8.83
Current year
5.65
Extreme 5.65
8.83
1 year
4.07
Extreme 4.0705
21.05
3 years
4.07
Extreme 4.0705
34.51
5 years
3.02
Extreme 3.02
34.51
10 years
1.97
Extreme 1.974
34.51
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 20-07-29
Director of Finance/CFO 50 18-07-31
Chief Tech/Sci/R&D Officer - 98-12-31
Members of the board TitleAgeSince
Director/Board Member 59 17-11-26
Chairman 78 17-11-26
Director/Board Member 68 19-07-24
More insiders
Date Price Change Volume
24-03-28 7.08 +1.43% 97 536
24-03-27 6.98 +2.80% 712,328
24-03-26 6.79 -0.59% 1,055,104
24-03-25 6.83 +1.49% 710,546
24-03-22 6.73 -2.04% 778,600

Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT

More quotes
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services. The Company’s services include clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization. It provides fully integrated and customized biomanufacturing services that support its customers from the early preclinical stage to commercial launch and supply.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
6.98 USD
Average target price
12.25 USD
Spread / Average Target
+75.50%
Consensus
  1. Stock
  2. Equities
  3. Stock Avid Bioservices, Inc. - Nasdaq